Cresco Labs Finalizes Acquisition of Hope Heal Health

Cresco Labs (CSE:CL), has received change in ownership approval from the Massachusetts Cannabis Control Commission, and has thus finalized the acquisition of Hope Heal Health Inc.

Currently, Hope Heal Health owns a facility and dispensary in Fall River Massachusetts, and is fully functioning as a cannabis cultivator and manufacturer. The company also holds several state licenses, including a retail license, manufacturing license, as well as a cultivation license. Hope Heal Health also has the ability to procure two additional retail licenses in Massachusetts

In addition, Hope Heal Health has also recently been granted a recreational cannabis license for its dispensary, meaning that following the acquisition, the company can still sell cannabis to medical-use patients, but will also be catering to adult-use customers through Cresco’s several cannabis brands.

Now that the acquisition is complete, Cresco plans to distribute its branded products in the Massachusetts adult-use cannabis market. The company owns several brands, including Remedi, Cresco, and Mindy’s Edibles.

Cresco Labs is a United States based cannabis operator, and is currently trading at $7.31 on the CSE.


Information for this briefing was found via Sedar and Cresco Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Silver’s Next Move May Be Built on a Much Stronger Base | Mani Alkhafaji – First Majestic Silver

Guanajuato Silver Q1 Earnings: They Finally Post Positive Net Income

We’re in a New Era of Gold Price Discovery | Ryan King – Equinox Gold

Recommended

Canadian Gold Maps Out 2026 Drill Plans Across Three Québec Projects

Mercado Minerals Drills 1,120 g/t Silver Equivalent Over 1.20 Metres At Copalito

Related News

Cresco Labs Posts $214.4 Million In Revenue, $23.7 Million Net Loss In Q1 2022

Cresco Labs (CSE: CL) released its Q1 2022 financials, highlighting a quarterly revenue of $214.4 million....

Wednesday, May 18, 2022, 11:28:00 AM

Cresco Labs Receives Court Approval To Proceed With Columbia Care Acquisition

Cresco Labs (CSE: CL) is inching closer to finalizing its previously announced acquisition of Columbia...

Friday, July 15, 2022, 08:09:23 AM

Cresco Labs Announces First Harvest at Illinois’ Largest Facility

Cresco Labs (CSE: CL) announced this morning that the firm has conducted its first harvest...

Monday, December 9, 2019, 08:43:15 AM

Cresco Labs Reports 2021 Financials: $821.7 Million In Revenue, $296.8 Million Net Loss

Cresco Labs (CSE: CL) released its Q4 and full-year 2021 financials, highlighting what it deems a...

Wednesday, March 23, 2022, 10:32:00 AM

#Potstocks Earnings Roundup: May 29

As we alluded to in an article released Monday morning, there were a number of...

Thursday, May 30, 2019, 07:00:51 AM